Pay in 4 interest-free payments of $5.68 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Novo Nordisk
Prescribing an unapproved new drug outside a trial is technically illegal under the FDCA (aside from narrow compassionate-use exceptions)
Miller C, Folkes LK, Mottley C, Wardman P, Mason RP
Acta Crystallographica
Liao, Y
The design of the sleeping fusion peptide plasmid is a strategic approach to creating a novel biological tool that combines the capabilities of cell-penetrating peptides, a fluorescent marker, and a DSIP for targeted research applications, particularly in the study of sleep mechanisms and potentially therapeutic interventions
US$ 23.12
US$ 20.60
US$ 24.83
US$ 25.32
US$ 24.02
